Cargando…
Cholesterol and hepatocellular carcinoma risk: reliable and actionable?
Autor principal: | Braillon, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007817/ https://www.ncbi.nlm.nih.gov/pubmed/33473165 http://dx.doi.org/10.1038/s41416-020-01249-x |
Ejemplares similares
-
RE: Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial
por: Braillon, Alain
Publicado: (2021) -
Vitamin C to Pregnant Smokers and Infant Airway Function: Missing the Forest for the Trees?
por: Braillon, Alain
Publicado: (2019) -
Comment on: “The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies”
por: Braillon, Alain
Publicado: (2019) -
Cost-effectiveness of screening for hepatocellular carcinoma: putting the cart before the horse
por: Braillon, Alain
Publicado: (2012) -
Surveillance programmes for hepatocellular carcinoma: evident-based medicine is not evidence-based medicine
por: Braillon, Alain
Publicado: (2009)